Dipeptidyl peptidase-4 inhibitor anagliptin reduces fasting apolipoprotein B-48 levels in patients with type 2 diabetes: A randomized controlled trial
二肽基肽酶-4抑制剂阿格列汀可降低2型糖尿病患者的空腹载脂蛋白B-48水平:一项随机对照试验
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0228004
Onoue, Takeshi; Goto, Motomitsu; Wada, Eri; Furukawa, Mariko; Okuji, Takayuki; Okada, Norio; Kobayashi, Tomoko; Iwama, Shintaro; Sugiyama, Mariko; Tsunekawa, Taku; Takagi, Hiroshi; Hagiwara, Daisuke; Ito, Yoshihiro; Morishita, Yoshiaki; Seino, Yusuke; Suga, Hidetaka; Banno, Ryoichi; Hamada, Yoji; Ando, Masahiko; Yamamori, Etsuko; Arima, Hiroshi